ConductScience.org, home

Library / Genes

CYP2D6: cytochrome P450 family 2 subfamily D member 6 (gene/pseudogene)

1 protein, 40 patents, 0 drugs, 0 trials, 4,215 NIH grants and 17,817 papers.

Gene 7

Its symbol and name are HGNC's, unless HGNC and NCBI Gene contradict each other.

FieldValueSource
SymbolCYP2D6HGNC
Namecytochrome P450 family 2 subfamily D member 6 (gene/pseudogene)HGNC
NCBI Gene ID1565NCBI Gene
HGNC IDHGNC:2625HGNC
EnsemblENSG00000100197NCBI Gene
AliasesCPD6, CYP2D, CYP2D7AP, CYP2D7BP, CYP2D7P2, CYP2D8P2, CYP2DL1, CYPIID6, P450-DB1, P450C2D, P450DB1NCBI Gene
Typeprotein-codingNCBI Gene

Proteins 1

Reviewed human proteins whose Swiss-Prot entry states the gene.

UniProt entryProteinLengthStructuresGene stated inSource
P10635Cytochrome P450 2D649714Ensembl, GeneID, HGNCUniProt

Patents 40

Patents whose sequence listing holds the protein exactly: the same sequence, by SHA-256, length and CRC-64. A sequence a patent lists is not always one it claims.

PublicationPublishedSEQ ID NOProteinSource
EP 4640849 A22025-10-294025P10635Espacenet
EP 4641201 A22025-10-2925071P10635Espacenet
JP 2025147176 A2025-10-0616584P10635Espacenet
JP 2025529142 A2025-09-041186P10635Espacenet
EP 4594342 A22025-08-06132P10635Espacenet
US 12371689 B22025-07-291186P10635Espacenet
JP 2025519096 A2025-06-244025P10635Espacenet
JP 2025517969 A2025-06-1225071P10635Espacenet
JP 2025508740 A2025-04-10133P10635Espacenet
JP 2025032204 A2025-03-1127002P10635Espacenet

Drugs 0

Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.

DrugChEMBL IDMechanismActionSource

Trials 0

Trials of those drugs. A trial joins the gene only through a drug that acts on it.

TrialDrugPhaseResults first postedSource

NIH grants 4215

NIH projects whose papers are about the gene, through NIH's grant-paper links.

ProjectTitleIts papers about the geneNewest fiscal yearSource
P30CA021765Cancer Center Support Grant (CCSG)362,025NIH's project files
P50CA116201Mayo Clinic Breast Cancer SPORE332,025NIH's project files
T32GM008425Indiana University Comprehensive Training in Clinical Pharmacology302,025NIH's project files
U24HG010615PharmGKB192,025NIH's project files
P30CA008748Cancer Center Support Grant182,025NIH's project files
P30CA015083Mayo Clinic Comprehensive Cancer Center Support Grant172,025NIH's project files
P30DK026743UCSF Liver Center172,025NIH's project files
U01HG006379EHR-based Genomic Discovery and Implementation [Funded Extension]172,025NIH's project files
ZIABC005562Xenobiotic receptors172,025NIH's project files
UL1TR001863Yale Clinical and Translational Science Award152,025NIH's project files

Papers 17817

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

PMIDFound bySource
42824314PubTator, text miningPubMed
42822376PubTator, text miningPubMed
42816374PubTator, text miningPubMed
42814596PubTator, text miningPubMed
42813508PubTator, text miningPubMed
42813501PubTator, text miningPubMed
42810749PubTator, text miningPubMed
42803946PubTator, text miningPubMed
42802548PubTator, text miningPubMed
42800901PubTator, text miningPubMed

The same record as JSON

Release gene-search-2026-11-11-0.1.0

ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

ChEMBL, through Open Targets: CC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence

ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

EMBL-EBI's patent proteins: EMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use

GenBank's patent files: GenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/

HGNC: CC0: https://www.genenames.org/about/license/

NCBI Gene: None named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/

NIH's project files and grant-paper links: Public domain (NIH RePORTER)

Open Targets: CC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence

PubTator 3: Public domain

UniProt: CC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license